News

Aphena Pharma Solutions Announces $21-Million Facility Expansion in Tennessee

September 23, 2020

The renovations are expected to be completed by Feb. 1, 2021 and, upon completion, Aphena will move its corporate headquarters to the new location.

Moderna, Chiesi Group Collaborate on Discovery and Development of mRNA Therapeutics

September 22, 2020

Moderna and Chiesi Group are collaborating on the discovery and development of mRNA therapeutics to treat pulmonary arterial hypertension.

Korean MFDS Approves Celltrion’s IND for Phase II/III Trial of COVID-19 Treatment

September 22, 2020

The Korean MFDS has given its approval for Celltrion to initiate a Phase II/III trial of its anti-COVID-19 monoclonal antibody treatment candidate, CT-P59.

ISPE Releases Cleaning Validation Guide

September 22, 2020

ISPE has released new guidance on the cleaning validation lifecycle, written by a group of experts and reviewed by regulators and practitioners.

Metrics Contract Services to Expand Greenville, NC Oral Solid Dosage Manufacturing Facility

September 22, 2020

The $10 million expansion, which will be completed and fully operational by February 2021, will add on 3760 square feet of production space.

Stevanato Group Partners with Bexson Biomedical on a Wearable Drug Delivery Device

September 22, 2020

The companies will work together to produce a wearable device that can subcutaneously deliver ketamine therapy as a non-opioid pain treatment.

AstraZeneca and Samsung Biologics to Enter into Long-Term Supply Agreement for Up to $545.6 Million

September 22, 2020

Samsung will offer large-scale commercial manufacturing for drug substance and drug products to support AstraZeneca’s biologics therapeutics capabilities in the Asia-Pacific region.

Legacy Pharmaceutical Packaging Rebrands as Legacy Pharma Solutions

September 22, 2020

The rebranding stems from the company’s expanded services which include 3PL services, supply chain transparency solutions, and retail pharma product procurement for over-the-counter medications.

Natoli Installs Tablet Press at its New Research and Training Facility

September 21, 2020

Natoli installed a NP-RD30 rotary tablet press for R&D at its new lab in Germany.

Roche Closes Agreement with Inflazome for $450 Million

September 21, 2020

Roche will gain full rights to Inflazome’s portfolio which includes clinical and preclinical orally available small molecule NLRP3 inhibitors.